Literature DB >> 18320189

Antibody variable-region sequencing as a method for hybridoma cell-line authentication.

Simon Koren1, Miha Kosmac, Anja Colja Venturini, Sendi Montanic, Vladka Curin Serbec.   

Abstract

Cross-contamination and misidentification of various cell lines is a widespread problem that can lead to spurious scientific conclusions. DNA fingerprinting is a powerful identification technique, which can be effectively used for the authentication of human cell lines. In contrast to human cancer cell lines, little attention has so far been given to establishing authentication practices for hybridoma cell lines. Since the majority of hybridomas stem from inbred animals, they have high genetic uniformity, which reduces the applicability of DNA fingerprinting. In the present study, we propose antibody variable-region sequencing as a method of choice for hybridoma cell-line authentication. This method focuses on the most diverse characteristic of hybridoma cell lines and thereby achieves a very high discriminatory power. The sequencing of light-chain variable regions has proven to be especially suitable for routine use because of its high success rate. Two other possible authentication methods, random amplified polymorphic DNA analysis and two-dimensional gel electrophoresis, were also examined. Compared to these and other methods that can be used for discrimination between hybridoma cell lines, variable-region sequencing has many advantages, most notably those of a very high discriminatory power, insensitivity to changes in experimental conditions, simple data analysis, and accessibility to most laboratories.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18320189     DOI: 10.1007/s00253-008-1386-5

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  4 in total

1.  Chemical alternative for cell identification and cross-contamination detection.

Authors:  Dhouha Msalbi; Jihene Elloumi-Mseddi; Bochra Hakim; Emna Sahli; Sami Aifa
Journal:  3 Biotech       Date:  2022-02-25       Impact factor: 2.406

2.  Specific binding of the pathogenic prion isoform: development and characterization of a humanized single-chain variable antibody fragment.

Authors:  Nives Skrlj; Tanja Vranac; Mara Popović; Vladka Curin Šerbec; Marko Dolinar
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

Review 3.  Prion Protein: The Molecule of Many Forms and Faces.

Authors:  Valerija Kovač; Vladka Čurin Šerbec
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

4.  Anti-idiotypic antibodies: a new approach in prion research.

Authors:  Anja Colja Venturini; Maja Bresjanac; Tanja Vranac; Simon Koren; Mojca Narat; Mara Popović; Vladka Curin Serbec
Journal:  BMC Immunol       Date:  2009-03-19       Impact factor: 3.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.